Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Viagra Non-Prescription Switch Would Face High Bar For Safety

This article was originally published in The Tan Sheet

Executive Summary

Perhaps the greatest hurdle to an Rx-to-OTC switch of Pfizer's Viagra would be the broad expansion of existing safety concerns due to self-selection and off-label use issues in an over-the-counter setting, experts tell "The Tan Sheet."

You may also be interested in...



Pfizer Pulls Back On European Viagra Switch As Questions Linger

Pfizer withdraws its application to switch Viagra 50 mg from prescription to nonprescription status through the European Medicines Agency's centralized process, the company said Nov. 20

Pfizer Pulls Back On European Viagra Switch As Questions Linger

Pfizer withdraws its application to switch Viagra 50 mg from prescription to nonprescription status through the European Medicines Agency's centralized process, the company said Nov. 20

Pfizer Pulls Back On European Viagra Switch As Questions Linger

Pfizer withdraws its application to switch Viagra 50 mg from prescription to nonprescription status through the European Medicines Agency's centralized process, the company said Nov. 20

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS100128

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel